Authors:
Lohr, M
Hoffmeyer, A
Kroger, JC
Freund, M
Hain, J
Holle, A
Karle, P
Knofel, WT
Liebe, S
Muller, P
Nizze, H
Renner, M
Saller, RM
Wagner, T
Hauenstein, K
Gunzburg, WH
Salmons, B
Citation: M. Lohr et al., Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma, LANCET, 357(9268), 2001, pp. 1591-1592
Authors:
Muller, P
Ostwald, C
Puschel, K
Brinkmann, B
Plath, F
Kroger, J
Barten, M
Nizze, H
Schareck, WD
Hauenstein, K
Liebe, S
Lohr, JM
Citation: P. Muller et al., Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: a prospective study in more than 100 patients, EUR J CL IN, 31(3), 2001, pp. 240-247
Authors:
Lohr, M
Bago, ZT
Bergmeister, H
Ceijna, M
Freund, R
Gelbmann, W
Gunzburg, WH
Jesnowski, R
Hain, J
Hauenstein, K
Henninger, W
Hoffmeyer, A
Karle, P
Kroger, JC
Kundt, G
Liebe, S
Losert, U
Muller, P
Probst, A
Puschel, K
Renner, M
Renz, R
Saller, R
Salmons, B
Schuh, M
Schwendenwein, I
von Rombs, K
Wagner, T
Walter, I
Citation: M. Lohr et al., Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study, J MOL MED-J, 77(4), 1999, pp. 393-398